On May 20, 2025, Longevity Health Holdings, Inc. was granted a conditional approval by Nasdaq to continue its listing, contingent on meeting initial listing requirements following a proposed merger with 20/20 Biolabs, Inc. A press release regarding this decision was issued on May 21, 2025.